AMBEV S.A. current report, Q3 FY2019

Business Context and Reporting Period

This Form 6-K filing by Ambev S.A. covers the period from August 1, 2019, to August 31, 2019. The report details consolidated transactions of securities and derivatives involving the company's Group and Related Persons, specifically the Board of Directors and Management, in compliance with Article 11 of CVM Instruction # 358/2002.

Key Financial Metrics

The filing does not provide corporate financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. It exclusively reports on insider trading activity.

Category Transaction Type Quantity (Shares) Total Volume (R$)
Group and Related Persons Buy (Option Exercise/Subscription) 40,078 793,544.40
Board of Directors Buy (Option Exercise/Subscription) 2,321,782 27,257,342.39
Board of Directors Sell 1,922,590 35,015,280.58
Management Buy/Sell 0 0.00

Material Changes

The filing does not provide comparative data against prior periods to determine material changes in trading volume or value. The document serves as a statutory disclosure of specific transactions occurring within the month of August 2019.

Outlook, Risks, and Commentary

The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies. It is a factual record of securities transactions.

Investor Verification Points

  • Net Selling by Directors: The Board of Directors executed a net sale of approximately 399,192 shares (2.32M bought vs. 1.92M sold) during the period.
  • Transaction Pricing: Verify the range of transaction prices, which varied significantly from R$ 0.44 to R$ 20.17, indicating a mix of option exercises at strike prices and market sales.
  • Management Activity: Confirm that no securities transactions were reported for the Management group during this period.
  • Regulatory Compliance: Ensure these transactions align with the company's insider trading policies and CVM regulations.